• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Efficacy and safety of mycophenolate mofetil for the treatment of acute and chronic GVHD in bone marrow transplant recipient.

作者信息

Basara N, Blau W I, Kiehl M G, Römer E, Rudolphi M, Bischoff M, Kirsten D, Sanchez H, Günzelmann S, Fauser A A

机构信息

Clinic for Bone Marrow Transplantation and Hematology/Oncology, Idar-Oberstein, Germany.

出版信息

Transplant Proc. 1998 Dec;30(8):4087-9. doi: 10.1016/s0041-1345(98)01351-7.

DOI:10.1016/s0041-1345(98)01351-7
PMID:9865306
Abstract
摘要

相似文献

1
Efficacy and safety of mycophenolate mofetil for the treatment of acute and chronic GVHD in bone marrow transplant recipient.霉酚酸酯治疗骨髓移植受者急慢性移植物抗宿主病的疗效和安全性。
Transplant Proc. 1998 Dec;30(8):4087-9. doi: 10.1016/s0041-1345(98)01351-7.
2
Mycophenolate Mofetil in the treatment of acute and chronic GVHD in hematopoietic stem cell transplant patients: four years of experience.霉酚酸酯用于治疗造血干细胞移植患者的急慢性移植物抗宿主病：四年经验
Transplant Proc. 2001 May;33(3):2121-3. doi: 10.1016/s0041-1345(01)01968-6.
3
Mycophenolate mofetil for the treatment of acute and chronic GVHD in bone marrow transplant patients.
Bone Marrow Transplant. 1998 Jul;22(1):61-5. doi: 10.1038/sj.bmt.1701281.
4
Mycophenolate mofetil for the prophylaxis of acute GVHD in HLA-mismatched bone marrow transplant patients.霉酚酸酯用于预防HLA配型不合的骨髓移植患者的急性移植物抗宿主病
Clin Transplant. 2000 Apr;14(2):121-6. doi: 10.1034/j.1399-0012.2000.140204.x.
5
New immunosuppressants in BMT/GVHD.
Transplant Proc. 2001 May;33(3):2220-2. doi: 10.1016/s0041-1345(01)01946-7.
6
Addition and drug monitoring of mycophenolate mofetil for GVHD prophylaxis in unrelated bone marrow transplantation.霉酚酸酯在非亲缘异基因骨髓移植中预防移植物抗宿主病的加用及药物监测
Bone Marrow Transplant. 2022 Jul;57(7):1198-1200. doi: 10.1038/s41409-022-01692-9. Epub 2022 May 2.
7
[Combination of mycophenolate mofetil with cyclosporine A and methotrexate for the prophylaxes of acute graft versus host disease in allogeneic peripheral stem cell transplantation].霉酚酸酯联合环孢素A和甲氨蝶呤预防异基因外周血干细胞移植中急性移植物抗宿主病
Zhonghua Yi Xue Za Zhi. 2002 Apr 25;82(8):507-10.
8
Use of intravenous mycophenolate mofetil for graft-versus-host disease prophylaxis in an allogeneic hematopoietic stem cell transplant recipient with an allergic reaction to cyclosporine and tacrolimus.在一名对环孢素和他克莫司过敏的异基因造血干细胞移植受者中，使用静脉注射霉酚酸酯预防移植物抗宿主病。
Bone Marrow Transplant. 2006 Aug;38(3):253-4. doi: 10.1038/sj.bmt.1705422. Epub 2006 Jun 19.
9
Prospective trial of mycophenolate mofetil-cyclosporine A prophylaxis for acute GVHD after G-CSF stimulated allogeneic bone marrow transplantation with HLA-identical sibling donors in patients with severe aplastic anemia and hematological malignancies.霉酚酸酯联合环孢素A预防急性移植物抗宿主病的前瞻性试验：在严重再生障碍性贫血和血液系统恶性肿瘤患者中，采用粒细胞集落刺激因子动员的人类白细胞抗原全相合同胞供者进行异基因骨髓移植后的应用。
Clin Transplant. 2009 Jan-Feb;23(1):33-8. doi: 10.1111/j.1399-0012.2008.00894.x. Epub 2008 Aug 22.
10
Different efficacy of mycophenolate mofetil as salvage treatment for acute and chronic GVHD after allogeneic stem cell transplant.霉酚酸酯作为异基因干细胞移植后急性和慢性移植物抗宿主病挽救治疗的不同疗效。
Eur J Haematol. 2004 Jul;73(1):56-61. doi: 10.1111/j.1600-0609.2004.00247.x.

引用本文的文献

1
Adverse events in second- and third-line treatments for acute and chronic graft--host disease: systematic review.急性和慢性移植物抗宿主病二线及三线治疗中的不良事件：系统评价
Ther Adv Hematol. 2020 Dec 8;11:2040620720977039. doi: 10.1177/2040620720977039. eCollection 2020.
2
Prophylaxis and treatment with mycophenolate mofetil in children with graft-versus-host disease undergoing allogeneic hematopoietic stem cell transplantation: a nationwide survey in Japan.霉酚酸酯对接受异基因造血干细胞移植的移植物抗宿主病患儿的预防和治疗：日本全国性调查
Int J Hematol. 2019 Apr;109(4):491-498. doi: 10.1007/s12185-019-02601-5. Epub 2019 Jan 29.
3
Efficacy of Mesenchymal Stem Cell Therapy for Steroid-Refractory Acute Graft-Versus-Host Disease following Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.
间充质干细胞治疗异基因造血干细胞移植后类固醇难治性急性移植物抗宿主病的疗效：一项系统评价和荟萃分析
PLoS One. 2015 Aug 31;10(8):e0136991. doi: 10.1371/journal.pone.0136991. eCollection 2015.
4
Mycophenolic acid derivative 118 improves outcome of skin grafts by suppressing IL-17 production.麦考酚酸衍生物 118 通过抑制白细胞介素-17 的产生改善皮肤移植物的预后。
Acta Pharmacol Sin. 2013 Jul;34(7):921-9. doi: 10.1038/aps.2013.14. Epub 2013 May 6.
5
Use of mycophenolate mofetil in patients received allogeneic hematopoietic stem cell transplantation in Japan.在日本，接受异基因造血干细胞移植的患者中使用霉酚酸酯。
Int J Hematol. 2011 Apr;93(4):523-531. doi: 10.1007/s12185-011-0817-8. Epub 2011 Apr 5.
6
Immunotherapy following hematopoietic stem cell transplantation: potential for synergistic effects.造血干细胞移植后的免疫治疗：协同效应的潜力。
Immunotherapy. 2010 May;2(3):399-418. doi: 10.2217/imt.10.20.
7
Management of acute graft-versus-host disease in children.儿童急性移植物抗宿主病的治疗。
Pediatr Clin North Am. 2010 Feb;57(1):273-95. doi: 10.1016/j.pcl.2009.11.007.
8
A high risk of life-threatening infectious complications in mycophenolate mofetil treatment for acute or chronic graft-versus-host disease.霉酚酸酯治疗急性或慢性移植物抗宿主病时存在发生危及生命的感染性并发症的高风险。
Int J Hematol. 2010 Apr;91(3):464-70. doi: 10.1007/s12185-010-0516-x. Epub 2010 Mar 10.
9
Pharmacokinetic modelling and development of Bayesian estimators for therapeutic drug monitoring of mycophenolate mofetil in reduced-intensity haematopoietic stem cell transplantation.霉酚酸酯在减低强度造血干细胞移植中治疗药物监测的药代动力学建模及贝叶斯估计器的开发
Clin Pharmacokinet. 2009;48(10):667-75. doi: 10.2165/11317140-000000000-00000.
10
Mycophenolate mofetil is effective and well tolerated in the treatment of refractory acute and chronic graft-versus-host disease.霉酚酸酯在治疗难治性急慢性移植物抗宿主病方面有效且耐受性良好。
Int J Hematol. 2006 Jan;83(1):80-5. doi: 10.1532/IJH97.05111.